A Systematic Review of the Anti-inflammatory Effects of Gallium Compounds

Victor de Albuquerque Wanderley Sales1, Taysa Renata Ribeiro Timóteo1, Natália Millena da Silva1

  • 1Laboratorio de Tecnologia dos Medicamentos, Federal University of Pernambuco (UFPE), Recife-PE, Brazil.

Abstract

Insights

Gallium compounds show promising anti-inflammatory effects in preclinical and human studies. Further research is needed to explore their potential for specific inflammatory conditions.

Area of Science:

  • Immunology
  • Pharmacology
  • Materials Science

Background:

  • Inflammation is a critical immune response but prolonged inflammation causes severe health issues.
  • Understanding inflammatory mechanisms is key to developing new therapies.

Purpose of the Study:

  • To systematically review preclinical and human studies on gallium compounds' anti-inflammatory activity.
  • To elucidate the mechanisms of action for gallium compounds in inflammation.
  • To cover literature published between 2000 and 2019.

Main Methods:

  • A comprehensive literature search was conducted across seven major bibliographical databases.
  • Study selection and review followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
  • Methodological quality assessment of included studies was performed.

Main Results:

  • Out of 3018 initial studies, 16 met the eligibility criteria for inclusion.
  • The selected studies demonstrated consistent and promising anti-inflammatory results for gallium compounds.
  • Evidence suggests potential therapeutic applications for gallium in managing inflammatory processes.

Conclusions:

  • Gallium compounds exhibit notable anti-inflammatory potential.
  • Further investigation into specific inflammatory conditions is warranted.
  • Targeted research can optimize gallium-based therapies.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
361
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.0K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
360
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
1.9K